Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

8.0%

2 terminated out of 25 trials

Success Rate

88.2%

+1.7% vs benchmark

Late-Stage Pipeline

16%

4 trials in Phase 3/4

Results Transparency

33%

5 of 15 completed with results

Key Signals

5 with results88% success

Data Visualizations

Phase Distribution

19Total
Not Applicable (5)
P 1 (3)
P 2 (7)
P 3 (2)
P 4 (2)

Trial Status

Completed15
Unknown4
Terminated2
Recruiting2
Not Yet Recruiting2

Trial Success Rate

88.2%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (25)

Showing 20 of 20 trials
NCT07431294Phase 1Not Yet RecruitingPrimary

A Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandociguat in People With Coronary Artery Disease

NCT07495813Phase 1RecruitingPrimary

A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease

NCT07362108Completed

Cardiovascular Events Related to Treated Coronary Arteries in Stable Multivessel CAD

NCT07348341Not Yet RecruitingPrimary

Coronary Laser Atherectomy Registry From an International Taskforce

NCT07187895Phase 2Terminated

Comparative Imaging of XTR004 PET and MIBI SPECT in Borderline Coronary Stenosis

NCT03384966Phase 2CompletedPrimary

A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease

NCT06123728RecruitingPrimary

MCG is Clinically Applied to Evaluate Myocardial Ischemic Function in Patients With Stable Coronary Artery Disease

NCT03782688CompletedPrimary

Precise Percutaneous Coronary Intervention Plan (P3) Study

NCT00911339Phase 3TerminatedPrimary

Mobilization of Endothelial Progenitor Cells Induced by Atorvastatin in Patients With Stable Coronary Artery Disease Treated With Anti-CD 34 Antibodies Coated Stents

NCT03313752Phase 3Unknown

Effects of SGLT2 Inhibition on Myocardial Insulin Sensitivity

NCT04434365Phase 1UnknownPrimary

Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease

NCT03312855Phase 2CompletedPrimary

Intracoronary Stenting and Antithrombotic Regimen: Lesion Platelet Adhesion as Selective Target of Endovenous Revacept

NCT02580851Not ApplicableCompletedPrimary

Magnetic Resonance Adenosine Perfusion Imaging as Gatekeeper of Invasive Coronary Intervention

NCT03089450Not ApplicableUnknown

To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent

NCT01209637Not ApplicableCompletedPrimary

Impact of Intensive Exercise Training on Coronary Collateral Circulation in Patients With Stable CAD

NCT00510588Not ApplicableCompletedPrimary

Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease

NCT01523392Phase 4CompletedPrimary

A Pharmacodynamic Study With Ticagrelor in African American Patients

NCT01523366Phase 4CompletedPrimary

A Pharmacodynamic Study With Ticagrelor in Hispanic Patients

NCT01118325Phase 2CompletedPrimary

An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery Disease

NCT01243099CompletedPrimary

Prospective Study to Assess DES Re-endothelization in BMS Restenosis and De-novo Lesions

Scroll to load more

Research Network

Activity Timeline